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More information is needed to better understand the effect of caffeine on sleep quality at the
community level. In a population-based, cross-sectional study design, we aimed to assess the
effect of caffeine intake on sleep quality by the use of a multivariate exposure-effect model,
adjusted for relevant confounders. All Atahualpa residents aged Z40 years were identiﬁed
during a door-to-door survey and interviewed with the Pittsburgh Sleep Quality Index (PSQI)
and a structured instrument designed to estimate the daily amount of caffeine intake. An
exposure-effect model was built using augmented inverse probability weighting taking into
account variables that were associated with exposure (using a probit model) and variables that
were associated with outcome (in a linear model). Out of 779 eligible individuals, 716 (92%) were
included. Consumption ofo100mg/day of caffeine was recorded in 320 (45%) participants, from
100 to 200mg/day in 299 (42%), and 4200mg/day in 97 (13%). Mean score in the PSQI was
4.572.2 points, with 203 (28%) individuals classiﬁed as poor sleepers (Z6 points). The exposure-
effect model, adjusted for variables associated with the exposure (symptoms of depression,
total cholesterol blood levels and smoking) and the outcome (age, symptoms of depression,
physical activity and fasting glucose levels), revealed no effect of caffeine intake in sleep quality
(average exposure effect: 0.027, 95% C.I.: 0.284 to 0.338, p¼0.866). This population-based study
shows that caffeine intake has no effect on sleep quality in community-dwelling adults living in
a rural village of Ecuador.
& 2015 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).ep. Production and Hosting by Elsevier B.V. This is an open access article under the CC BY-
licenses/by-nc-nd/4.0/).
ox 522970, Miami, FL 33152-2970, United States.
com (O.H. Del Brutto).
an Association of Sleep.
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Caffeine, an adenosine receptor antagonist, is the most
commonly used legal stimulant in the world. Intake of this
substance has long been associated with increased alertness
as well as with improved motor and cognitive performance
[1,2]. These beneﬁcial effects might be counterbalanced by
impairment of sleep quality. However, from the very ﬁrst
study attempting to demonstrate the effects of caffeine
intake on sleep quality, it was noticed a widespread indivi-
dual variability in this relationship [3]. Further studies have
shown contradictory results, but most of them have been
limited to small numbers of participants, to certain groups of
individuals, or under artiﬁcial circumstances that might not
be representative of the population at large [4–7].
Recent studies have shown that age, tolerance, differences
in caffeine bioavailability (prolonged half-life), genetic pre-
disposition and even external factors such as sleep depriva-
tion, may account for the observed differences on the effects
of caffeine intake on sleep quality [8–10]. More information is
needed to better understand the effect of caffeine intake on
sleep quality in different populations. In this study, we aimed
to assess the naturalistic effect of caffeine intake on sleep
quality at night in community-dwellers adults living in a
quiet rural Ecuadorian village.2. Methods
2.1. Study population
Atahualpa is a village representative of rural coastal Ecuador.
The weather is hot and dry, with 12 daily hours of sunlight all
over the year. Inhabitants do not migrate, and a sizable
proportion of them have never visited large urban centers.
More than 95% of the population belongs to the Ecuadorian
native/Mestizo ethnic group, and their living characteristics
are homogeneous, as detailed elsewhere [11]. There are no
fast-food restaurants or coffee shops in the village, and most
people eat at home. Atahualpa has street lighting but there
are no lighted or neon signs. Shift work is quite uncommon
(less than 1% of the population work as security guards
during nightly hours), and light or noise pollution are practi-
cally inexistent during nightly hours in the village.2.2. Study design
Using a population-based, cross-sectional study design, all
Atahualpa residents aged Z40 years identiﬁed during door-
to-door surveys and enrolled in the Atahualpa Project were
interviewed with ﬁeld instruments to assess the average
amount of daily caffeine intake and the quality of sleep in
the month before the survey. The effect of caffeine intake on
sleep quality was assessed by the use of an exposure-effect
model adjusted for relevant confounders. The Institutional
Review Board of Hospital-Clínica Kennedy, Guayaquil, Ecua-
dor (FWA 00006867) approved the protocol and the informed
consent form.2.3. Caffeine consumption
Caffeine intake (during the month before the survey) was
assessed by direct face-to-face interviews with the use of a
structured questionnaire that inquired about the average
number of cups/servings of coffee, tea, chocolate (beverages
or bars), caffeine-containing soft drinks and energy drinks
ingested per day, on the basis of the content of each of these
products 〈http://www.energyﬁend.com/the-caffeine-database〉;
in addition, use of caffeine-containing pills (showing the
participants a list of locally available medications) was speci-
ﬁcally inquired and recorded.
2.4. Sleep quality investigation
We used a validated Spanish version of the Pittsburg Sleep
Quality Index (PSQI) [12]. This instrument consists of a
combination of Likert-type and open ended questions asses-
sing sleep duration (total amount of sleep obtained during
the nocturnal sleep episode), sleep disturbances (symptoms
that change sleeping habits), sleep latency (length of time
that it takes to fall asleep), day dysfunction due to sleepiness
(daytime somnolence), sleep efﬁciency (ratio of time spent
asleep to the amount of time in bed), overall sleep quality
(self-perceived satisfaction with sleep), and medications
needed to sleep (use of sedatives, sleep inductors, etc.). The
maximum score is 21 points, and the cutoff value for poor
sleep quality is Z6 points.
2.5. Clinical covariates investigated
Demographics, level of education, alcohol intake, symptoms
of depression and cardiovascular risk factors were assessed
through direct interviews and procedures previously
described in the Atahualpa Project [13,14]. In brief, alcohol
intake was dichotomized in r50 or 450 g/day; symptoms of
depression were assessed by the depression axis of the
depression–anxiety–stress-21 scale (a reliable ﬁeld instru-
ment that measures dysphoria, hopelessness, devaluation
of life, self-deprecation, lack of interest/involvement, anhe-
donia, and inertia [15]), and cardiovascular risk factors were
investigated by the use of the seven metrics proposed by the
American Heart Association to assess the cardiovascular
health status (smoking status, body mass index, physical
activity, diet, blood pressure, fasting glucose, and total cho-
lesterol blood levels) [16].
2.6. Statistical analyses
Data analyses were carried out by using STATA version 14
(College Station, TX, USA). In the univariate analysis, we
separately evaluated the association between the amount of
caffeine intake and the quality of sleep with each of the
confounding variables. For these comparisons, continuous
variables used linear models and categorical variables either
x2 or Fisher exact test as appropriate. Thereafter, we con-
structed separate exposure (caffeine intake) and effect (sleep
quality) models to determine which variables were signiﬁcantly
associated with either the exposure or the effect. An exposure-
effect model, which takes into account the confounding effect
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S l e e p S c i e n c e 9 ( 2 0 1 6 ) 3 5 – 3 9 37of some variables over exposure and over outcome, was built
using augmented inverse probability weighting taking into
account variables that were associated with exposure using a
probit model and variables that were associated with outcome
in a linear model. The association between exposure and
outcome was then ascertained in the form of the average
exposure effect of caffeine intake on sleep quality after adjust-
ing for all confounders.T
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–3. Results
Information on caffeine intake and sleep quality was avail-
able in 716 (92%) out of 779 eligible individuals. Mean age was
61713 years, 405 (57%) were women, 450 (63%) had primary
school education only, 130 (18%) admitted alcohol consump-
tion of 450 g/day, and 84 (12%) had symptoms of depression.
Regarding cardiovascular risk factors, 27 (4%) individuals
were smokers, 49 (7%) had poor physical activity, 32 (4%)
had a poor diet, 184 (26%) had a body mass index Z30 kg/m2,
256 (36%) had blood pressure Z140/90 mmHg, 209 (29%) had
fasting glucose levels Z126 mg/dL, and 83 (12%) had total
cholesterol levels Z240 mg/dL.
Consumption of o100 mg/day of caffeine was recorded in
320 (45%) participants, from 100 to 200 mg/day in 299 (42%),
and4200 mg/day in the remaining 97 (13%). The main source
of caffeine intake was coffee, which was most often con-
sumed early in the morning and in the late afternoon.
Overall, 115 (16%) individuals admitted daily ingestion of
Z2 cups of coffee, 267 (37%) between 1 and 2 cups, 147 (21%)
less than one, and the remaining 187 (26%) reported no intake
of coffee at all. Second in importance were caffeine-
containing soft-drinks (consumed by 67% of the population).
Energy drinks were eventually consumed and only by men
during working hours, while chocolate (often with milk) was
a preferred beverage for women during or after dinner.
Consumption of black tea was reported by less than 5% of
the population and was irrelevant to the average amount of
caffeine intake in most cases. The intake of caffeine-
containing pills (pain relievers) was also uncommon and
irrelevant for the main ﬁndings.
Mean score in the PSQI was 4.572.2 points, with 203 (28%)
individuals classiﬁed as poor sleepers (Z6 points). Of inter-
est, more than 90% of individuals admitted to be regularly
awake before 8 am (even in weekends), and nobody acknowl-
edged the use more than two sleeping pills per month. To
conﬁrm this, we visited local drug stores and inquired
pharmacists who conﬁrmed that prescription sleep medica-
tions are rarely sold.
Characteristics of participants across categories of caffeine
intake and sleep quality are summarized in Table 1. In
univariate analyses, depression was the single variable sig-
niﬁcantly associated with higher amounts of caffeine intake.
On the other hand, individuals with poor sleep quality were
older, less educated, reported worse physical activity and had
more often symptoms of depression than those with good
sleep quality.
An exposure logistic regression model showed signiﬁcant
association of the amount of caffeine intake with symptoms
of depression (p¼0.031) and total cholesterol blood levels
S l e e p S c i e n c e 9 ( 2 0 1 6 ) 3 5 – 3 938(p¼0.042), and a marginal association with smoking status
(p¼0.061). A generalized lineal model showed signiﬁcant
association of sleep quality (continuous PSQI score) with
age (po0.001), symptoms of depression (po0.001) and physi-
cal activity (p¼0.009), and marginal association with fasting
glucose levels (p¼0.069). The exposure-effect model, adjusted
for relevant confounders, revealed no effect of caffeine intake
on sleep quality (average exposure effect: 0.027, 95% C.I.:
0.284 to 0.338, p¼0.866).4. Discussion
This population-based study shows that caffeine intake has
no effect on sleep quality in community-dwelling adults
living in a quiet rural village of Ecuador. As previously noted,
the effect of caffeine intake on sleep quality at the population
level has been scarcely investigated and, to our knowledge,
there is only one study in 181 community-dwellers showing
no relationship between these variables [17].
The assessment of the effect of caffeine intake on sleep
quality at the population level may be complicated by
personal experiences of given individuals, as it is possible
that those who think are “sensitive to coffee” avoid this
substance at night. In the present study, however, we
quantiﬁed the total amount of caffeine intake from sources
other than coffee. A 500 ml bottle of Pepsi© or Coca-Cola© (the
most commonly consumed soft drinks in the village) contain
more than 40 mg of caffeine, which if consumed at dinner,
would be enough to keep plasma caffeine concentrations
over the night. In Ecuador, labels of these soft drinks just
mention their caffeine, but there is no additional information
about the amounts of milligrams per serving.
Caffeine half-life has been estimated to be about six hours
but wide variability exists among individuals, and it is known
to be modiﬁed by age, alcohol intake, pregnancy, liver failure
and several other conditions and diseases [18–20]. Moreover,
it has been shown that residual caffeine in concentrations
enough to be associated with poor sleep quality, may be
detected in saliva up to 16 h after a single 200 mg dose of
coffee [21]. Therefore, assessment of day-long consumption
of caffeine should not be seen as a major limitation of the
present study. Nevertheless, further studies should formally
investigate differences between morning and late afternoon
caffeine intake in sleep quality to conﬁrm this assumption.
Another important aspect to be considered in the context
of our ﬁndings is the milieu of Atahualpa residents, since
light and noise pollution is virtually nonexistent during sleep
hours. These factors, which are known to negatively inﬂu-
ence sleep quality [22], might enhance potential detrimental
effects of caffeine intake in some individuals. The absence of
light and noise pollution is common to most rural villages of
developing countries and is a different scenario to that seen
in most of the developed world. Such differences must be
taken into account when analyzing the results of the present
study, which might not represent the reality of urban centers.
We did not investigated genetic variations in the Adeno-
sine A2a receptor gene or other candidates genes that may
explain the “resistance” of caffeine intake [9,10]. This is a
limitation of the present study, particularly in view of theethnic homogeneity of our participants. It is also possible that
relatively small amounts of caffeine intake by some Ata-
hualpa residents accounted for the lack of effect in sleep
quality in the entire cohort. On the contrary, the population-
based design with unbiased selection of participants and the
ﬁeld instruments used for obtaining information about total
amount of caffeine intake and sleep quality, argue for the
strengths of our ﬁndings. Further support for the validity of
our results are the associations observed in the separate
exposure and effect models. Caffeine intake was inversely
associated with symptoms of depression and directly with
total cholesterol blood levels, as reported by other investiga-
tors [23,24], and poor sleep quality was directly associated
with age, symptoms of depression and poor physical activity,
as previously described [25,26].Conﬂicts of interest
Nothing to disclose.Funding
This study was partially supported by Universidad Espíritu
Santo – Ecuador, Guayaquil, Ecuador.
r e f e r e n c e s
[1] Snel J, Lorist MM. Effects of caffeine on sleep and cognition.
Prog Brain Res 2011;190:105–17.
[2] Rivera-Oliver M, Dı´az-Rı´os M. Using caffeine and other
adenosine receptor antagonists and agonists as therapeutic
tools against neurodegenerative diseases: a review. Life Sci
2014;101(1–2):1–9.
[3] Hollingworth HL. The influence of caffeine alkaloid on the
quality and amount of sleep. Am J Psychol 1912;23(1):89–100.
[4] Shilo L, Sabbah H, Hadari R, Kovatz S, Weinberg U, Dolve S, et
al. The effects of coffee consumption on sleep and melatonin
secretion. Sleep Med 2002;3(3):271–3.
[5] Owens JA, Mindell J, Baylor A. Effect of energy drink and
caffeinated beverage consumption on sleep, mood, and
performance in children and adolescents. Nutr Rev 2014;72
(Suppl. 1):S65–71.
[6] Keenan EK, Tiplady B, Priestley CM, Rogers PJ. Naturalistic
effects of five days of bedtime caffeine use on sleep, next-day
cognitive performance, and mood. J Caffeine Res 2014;4
(1):13–20.
[7] Postuma RB, Lang AE, Munhoz RP, Charland K, Moscovich M,
Filla L, et al. Caffeine for treatment of Parkinson disease. A
randomized controlled trial. Neurology 2012;79(7):651–8.
[8] Robillard R, Bouchard M, Cartier A, Nicolau L, Carrier J. Sleep
is more sensitive to high doses of caffeine in the middle
years of life. J Psychopharmacol 2015;29(6);29(6) 688-67.
[9] Luciano M, Zhu G, Kirk KM, Gordon SD, Heath AC, Mon-
tgomery GW, et al. “No thanks, it keeps me awake”: the
genetics of coffee-attributed sleep disturbance. Sleep 2007;30
(10):1378–86.
[10] Re´tey JV, Adam M, Khatami R, Luhmann UF, Jung HH, Berger
W, et al. A genetic variation in the adenosine A2A receptor
gene (ADORA2A) contributes to individual sensitivity to
caffeine effects on sleep. Clin. Pharmacol Ther 2007;81
(5):692–8.
S l e e p S c i e n c e 9 ( 2 0 1 6 ) 3 5 – 3 9 39[11] Del Brutto OH, Pen˜aherrera E, Ochoa E, Santamarı´a M,
Zambrano M, Del Brutto VJ. Door-to-door survey of cardio-
vascular health, stroke, and ischemic heart disease in rural
coastal Ecuador – the Atahualpa Project: methodology and
operational definitions. Int J Stroke 2014;9(3):367–71.
[12] Del Brutto OH, Mera RM, Farfa´n R, Castillo PR. Cerebrovas-
cular correlates of sleep disorders – rational and protocol of a
door-to-door survey in rural coastal Ecuador. J Stroke Cere-
brovasc Dis 2014;23(5):1030–9.
[13] Del Brutto OH, Dong C, Rundek T, Elkind MSV, Del Brutto VJ,
Sacco RL. Cardiovascular health status among Caribbean
Hispanics living in Northern Manhattan and Ecuadorian
Natives/Mestizos in rural coastal Ecuador: a comparative
study. J Community Health 2013;38(4):634–41.
[14] Del Brutto OH, Mera RM, Del Brutto VJ, Maestre GE, Gardener
H, Zambrano M, et al. Influence of depression, anxiety and
stress on cognitive performance in Community-dwelling
older adults living in rural Ecuador: results of the Atahualpa
Project. Geriat Gerontol Int 2015;15(4):508–14.
[15] Osman A, Wong JL, Bagge CL, Freedenthal S, Gutierrez PM,
Lozano G. The depression anxiety stress scale – 21 (DASS-21):
further examination of dimensions, scale reliability, and
correlates. J Clin Psychol 2012;68(12):1322–38.
[16] Lloyd-Jones D, Hong Y, Labarthe D, Mozaffarian D, Appel
LJ, Van Horn L, et al. American Heart Association strategic
planning task force and statistics committee. Defining
and setting national goals for cardiovascular health pro-
motion. The American Heart Association’s strategic
impact goal through 2020 and beyond. Circulation
2010;121(4):586–613.[17] Curless R, French JM, James FW, Wynne HA. Is caffeine a
factor in subjective insomnia of elderly people? Age Ageing
1993;22(1):41–5.
[18] Balogh A, Harder S, Vollandt R, Staib AH. Intra-individual
variability of caffeine elimination in health subjects. Int J
Clin Pharmacol Ther Toxicol 1993;30(10):383–7.
[19] Lewis FW, Rector WG. Caffeine clearance in cirrhosis. The
value of simplified determinations of liver metabolic capa-
city. J Hepatol 1992;14(2–3):157–62.
[20] Lane JD, Steege JF, Rupp SL, Kuhn CM. Menstrual cycle effects
on caffeine elimination in the human female. Eur J Clin
Pharmacol 1992;43(5):543–6.
[21] Landolt HP, Werth E, Borbe´ly AA, Dijk DJ. Caffeine intake
(200 mg) in the morning affects human sleep and EEG power
spectra at night. Brain Res 1995;675(1–2):67–74.
[22] Halperin D. Environmental noise and sleep disturbances: a
threat to health? Sleep Med 2004;7(4):209–12.
[23] Grosso G, Micek A, Pajak A, Castellano S, Galvano F. Coffee, tea,
caffeine and risk of depression: a systematic review and dose-
response meta-analysis of observational studies. Mol Nutr
Food Res 2016;3(1):223–34.
[24] Jossa F, Krogh V, Farinaro E, Panico S, Giumetti D, Galasso R,
et al. Coffee and serum lipids: findings from the Olivetti
Heart Study. Ann Epidemiol 1993;3(3):250–5.
[25] Ouellet N, Morris DL. Sleep satisfaction of older adults living
in the community. J Gerontol Nurs 2006;32(10):5–11.
[26] Song Y, Dzierzewski JM, Fung CH, Rodriguez JC, Jouldjian S,
Mitchell MN, et al. Association between sleep and physical
function in older veterans in an adult day healthcare pro-
gram. J Am Geriatr Soc 2015;63(8):1622–7.
